Qianwen Cui
Science Island Branch
Hefei, 230026, China
Hefei, 230026, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.
Journal: International journal of molecular sciences
Published: January 23, 2025
Preventing liver carcinogenesis through the use of inhibitors targeting metabolic enzymes ACLY, G6PD, and TYMS, combined with 9-cis retinoic acid.
Journal: International journal of biological macromolecules
Published: December 02, 2024
Shenqi Sanjie Granules induce Hmox1-mediated ferroptosis to inhibit colorectal cancer.
Journal: Heliyon
Published: May 21, 2024
GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer.
GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: February 23, 2024
Unleashing the Power of Cold Atmospheric Plasma: Inducing Mitochondria Damage-Mediated Mitotic Catastrophe.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 21, 2024
WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.
WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.
Journal: Current cancer drug targets
Published: January 08, 2024
Integrated Bioinformatics and Machine Learning Analysis Identify ACADL as a Potent Biomarker of Reactive Mesothelial Cells.
Journal: The American journal of pathology
Published: September 22, 2023
A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes.
Journal: Biochemistry and biophysics reports
Published: December 23, 2022
The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target.
Journal: Molecules (Basel, Switzerland)
Published: November 05, 2022
HMGB3 is a potential diagnostic marker for early cervical lesion screening.
Journal: Genes & diseases
Published: October 13, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026